Viktor VráblikAssociateSquire Patton Boggs (US) LLPWebsitewww.squirepattonboggs.comOrganization ProfileFull ProfileBlogwww.squirepattonboggs.com/en/blogsConnectEmailTwitterLinkedIn+420 221 662 268 Professional Biography Viktor Vráblik’s practice focuses mainly on labour, technology and corporate matters. More Legal and Business Bylines From Viktor Vráblik Ferrari Loses Race for 250 GTO Trademark: Risks Arising From Non-Use of Registered Trademarks - (Posted On Thursday, November 19, 2020) Current Legal Analysis Back into the Ring: A Review of 2023 Texas Environmental Legislation and What’s Ahead for 2025 by: Jordan Rodriguez Governmental Practice Cybersecurity and Data Protection: 2024 Recap & 2025 Forecast Alert by: Townsend L. Bourne , Nikole Snyder Still Waiting—Massachusetts Pay Reporting Guidance Not Yet Published by: Mark H. Burak , James A. Patton Top Seven Tips for Law Firm CRM Success in 2025 by: Christina R. Fritsch JD FinCEN Seeks SCOTUS Ruling on Corporate Transparency Act Injunction by: Kiernan L. Ignacio , Kathleen M. Porter Why You Need a Lawyer to Review Your LOI Before Selling Your Business by: S. Graham Simmons, III Scientific Information on Unapproved Uses of Medical Products: FDA’s Final Guidance on Firm Communication to Health Care Providers by: Madeline S. Knight , Kyle Y. Faget California Governor Issues Executive Order Targeting Ultra-Processed Foods and Food Dyes by: Food and Drug Law at Keller and Heckman Upcoming Events Jan 8 2025 Key Proposals in the CY2026 Medicare Advantage and Part D Proposed Rule Jan 8 2025 Whistleblower Protections: Navigating Health Care Employment & Labor Rights Jan 8 2025 TSCA 30/30 - January 8, 2025 Jan 9 2025 2025 Enforcement Outlook | The Trump Administration’s Regulatory Landscape Jan 14 2025 What to Expect in Chemicals Policy and Regulation and on Capitol Hill in 2025 Jan 14 2025 Tariffs and Trade Under Trump 47: What to Watch Post-Inauguration Jan 15 2025 Healthy AI Roundtable Chicago Jan 15 2025 Polsinelli's FDA Webinar Series: Part One Print
